Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1985 Jun;51(6):805–808. doi: 10.1038/bjc.1985.125

Antibody guided lymphangiography in the staging of cervical cancer.

A A Epenetos
PMCID: PMC1977082  PMID: 4005140

Abstract

Iodine-123-labelled tumour associated monoclonal antibody HMFG2 was administered intralymphatically at a time that cannulation of pedal lymphatic vessels was performed for standard lymphangiography in 6 patients with cervical cancer. Gamma camera images were taken at 2 h and 24 h after injection of antibody and at a similar time that X-ray lymphangiography was performed. Five out of the 6 standard lymphangiograms were reported as normal whilst one showed definite evidence of metastasis. Antibody guided analysis of the abnormal lymphangiogram confirmed the presence of abnormality. Also, marked non-specific uptake of antibody was seen on all lymphangiograms. It is concluded that, in order for monoclonal antibody guided lymphangiography to become a useful adjunct to standard lymphangiography, further improvements are needed to reduce non-specific uptake by normal lymphatics.

Full text

PDF
805

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arklie J., Taylor-Papadimitrious J., Bodmer W., Egan M., Millis R. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer. 1981 Jul 15;28(1):23–29. doi: 10.1002/ijc.2910280105. [DOI] [PubMed] [Google Scholar]
  2. Epenetos A. A., Britton K. E., Mather S., Shepherd J., Granowska M., Taylor-Papadimitriou J., Nimmon C. C., Durbin H., Hawkins L. R., Malpas J. S. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours. Lancet. 1982 Nov 6;2(8306):999–1005. doi: 10.1016/s0140-6736(82)90046-0. [DOI] [PubMed] [Google Scholar]
  3. Kemshead J. T., Goldman A., Fritschy J., Malpas J. S., Pritchard J. Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders. Lancet. 1983 Jan 1;1(8314-5):12–15. doi: 10.1016/s0140-6736(83)91559-3. [DOI] [PubMed] [Google Scholar]
  4. Piver M. S., Wallace S., Castro J. R. The accuracy of lymphangiography in carcinoma of the uterine cervix. Am J Roentgenol Radium Ther Nucl Med. 1971 Feb;111(2):278–283. doi: 10.2214/ajr.111.2.278. [DOI] [PubMed] [Google Scholar]
  5. Rainsbury R. M., Ott R. J., Westwood J. H., Kalirai T. S., Coombes R. C., McCready V. R., Neville A. M., Gazet J. C. Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet. 1983 Oct 22;2(8356):934–938. doi: 10.1016/s0140-6736(83)90452-x. [DOI] [PubMed] [Google Scholar]
  6. Sullivan D. C., Silva J. S., Cox C. E., Haagensen D. E., Jr, Harris C. C., Briner W. H., Wells S. A., Jr Localization of I-131-labeled goat and primate anti-carcinoembryonic antigen(CEA) antibodies in patients with cancer. Invest Radiol. 1982 Jul-Aug;17(4):350–355. doi: 10.1097/00004424-198207000-00007. [DOI] [PubMed] [Google Scholar]
  7. Weinstein J. N., Steller M. A., Keenan A. M., Covell D. G., Key M. E., Sieber S. M., Oldham R. K., Hwang K. M., Parker R. J. Monoclonal antibodies in the lymphatics: selective delivery to lymph node metastases of a solid tumor. Science. 1983 Oct 28;222(4622):423–426. doi: 10.1126/science.6623082. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES